Evaluation of erlotinib for the treatment of patients with non-small cell lung cancer with epidermal growth factor receptor wild type.

Autor:	FUMIHIKO HIRAI1, MAKOTO EDAGAWA1, SHINICHIRO SHIMAMATSU1, RYO TOYOZAWA1, GOUJI TOYOKAWA1, KANAME NOSAKI1, MASAFUMI YAMAGUCHI1, TAKASHI SETO1, MITSUHIRO TAKENOYAMA1, YUKITO ICHINOSE1
Zdroj:	Oncology Letters. Jul2017, Vol. 14 Issue 1, p306-312. 7p. 4 Charts, 2 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu